Notable Analyst Rating Changes 6/25: GD, NDAQ, JBL, BP Upgraded; BA, RPM, BTRX Downgraded
More News related to BA
- Boeing Statement: Renegotiation Fails; Strike Called
- Boeing (BA) Sinks On Machinists Strike; Company May Have To Pay Up
- Saga Airlines Orders Two Boeing Next-Generation 737-800s
- Boeing Statement on IAM Contract Vote
- Boeing Comments on Results of IAM Contract Vote
More News related to BP
- Titan Oil and Gas Signs Green Project Acquisition Agreement Following Release of Business Plan
- FedEx Freight and BP Solar Complete Second Solar Power Installation
- Reducing Carbon Footprint with Sunrise Solar
- David Moenning's Daily State of the Markets: 9/3
- Notable Analyst Rating Changes 9/3: X, UTX, BP, ARQL Upgraded; CAG, TWX, LLTC, CRDN Downgraded
More News related to BTRX
- Agile Therapeutics Appoints Industry Expert, Al Altomari, as Chairman of Its Board of Directors
- FTN Midwest Downgrades Barrier Therapeutics (BTRX) to Neutral
- Stiefel Laboratories, Inc. Successfully Completes Tender Offer for Shares of Barrier Therapeutics, Inc.
- Stiefel Laboratories, Inc. Successfully Completes Tender Offer for Shares of Barrier Therapeutics, Inc.
- Stiefel Laboratories Announces Expiration of Waiting Period to Acquire Barrier (BTRX)
StreetInsider.com Notable Analyst Rating Changes:
UPGRADES:
Goldman Sachs upgrades General Dynamics Corp. (NYSE: GD) from Neutral to Buy, maintaing its $95 price target.
Piper Jaffray upgrades NASDAQ (NASDAQ: NDAQ) from Neutral to Buy with a $43 price target. The firm also lowers their 2008 and 2009 EPS estimates from $1.90/$2.16 to $1.88/$2.37.
Merrill Lynch upgrades Jabil Circuit (NYSE: JBL) from Neutral to Buy.
Morgan Stanley upgrades BP (NYSE: BP) from Equal-Weight to Overweight, calling the stock its preferred supermajor in Europe.
For daily real-time Upgrades go to http://www.streetinsider.com/Upgrades
DOWNGRADES:
Goldman Sachs downgrades Boeing (NYSE: BA) from Neutral to Sell, and adds the stock to their Conviction Sell List. Goldman cited a weak economy and surging fuel prices.
KeyBanc downgrades RPM International (NYSE: RPM) from Buy to Hold.
Roth Capital downgrades Barrier Therapeutics (Nasdaq: BTRX) from Buy to Hold on acquisition news.
For daily real-time Downgrades go to http://www.streetinsider.com/Downgrades
NEW COVERAGE:
J.P. Morgan initiates coverage on Schering-Plough (NYSE: SGP) with an Overweight.
J.P. Morgan initiates coverage on Merck (NYSE: MRK) with an Overweight rating.
Citi starts Altria (NYSE: MO) and Philip Morris International (NYSE: PM) at Buy and Reynolds American (NYSE: RAI) at Hold.
For daily real-time New Coverage go to http://www.streetinsider.com/New+Coverage
Related Categories
Special ReportsStocks Mentioned
-0.14
+0.35Related Entities
- Goldman Sachs Conviction Sell List
- Piper Jaffray
- JPMorgan
- Goldman Sachs
- Citi
- KeyBanc
- Morgan Stanley
- Merrill Lynch
- Roth Capital
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
